EVALUASI HASIL PENGOBATAN ADJUVAN TAMOKSIFEN PADA PASIEN KANKER PAYUDARA DI RSUP Dr. M. DJAMIL PADANG / THE EVALUATION OF ADJUVANT TAMOXIFEN THERAPY RESULT IN BREAST CANCER PATIENT AT Dr. M. DJAMIL PADANG HOSPITAL

MUHAMMAD, FADHIL (2017) EVALUASI HASIL PENGOBATAN ADJUVAN TAMOKSIFEN PADA PASIEN KANKER PAYUDARA DI RSUP Dr. M. DJAMIL PADANG / THE EVALUATION OF ADJUVANT TAMOXIFEN THERAPY RESULT IN BREAST CANCER PATIENT AT Dr. M. DJAMIL PADANG HOSPITAL. Diploma thesis, UNIVERSITAS ANDALAS.

[img]
Preview
Text (abstrak)
COVER ABSTRAK.pdf - Published Version

Download (224kB) | Preview
[img]
Preview
Text (BAB PENDAHULUAN)
2. BAB 1.pdf - Published Version

Download (568kB) | Preview
[img]
Preview
Text (BAB PENUTUP)
3. BAB 6.pdf - Published Version

Download (125kB) | Preview
[img]
Preview
Text (DAFTAR PUSTAKA)
4. DAFTAR PUSTAKA.pdf - Published Version

Download (213kB) | Preview
[img] Text (SKRIPSI)
5. SKRIPSI.pdf - Published Version
Restricted to Repository staff only

Download (4MB)

Abstract

EVALUASI HASIL PENGOBATAN ADJUVAN TAMOKSIFEN PADA PASIEN KANKER PAYUDARA DI RSUP Dr. M. DJAMIL PADANG Oleh MUHAMMAD FADHIL 1310311146 ABSTRAK Kanker payudara merupakan kanker yang paling banyak terjadi pada perempuan di dunia. Beberapa dekade terakhir,pengobatan adjuvan tamoksifen merupakan jenis pengobatan yang banyak digunakan. Penelitian ini bertujuan mengevaluasi hasil pengobatan tamoksifen dalam hal disease-free survival, survival rate dan efek samping pengobatan adjuvan tamoksifen. Penelitian deskriptif retrospektif ini dilakukan pada bulan September 2016 hingga Desember 2016 di RSUP Dr. M. Djamil Padang dengan menggunakan data sekunder 100 sampel yang diambil dari rekam medik bagian Bedah Onkologi RSUP Dr. M. Djamil Padang dan data primer 100 sampel melalui wawancara. Analisis univariat dan analisis metode Kaplan-Meier digunakan dalam penelitian ini. Hasil pada penelitian ini didapatkan kelompok usia terbanyak adalah 50-59 tahun.. Disease-free survival untuk 5 tahun adalah 0,727 dan survival rate untuk 5 tahun adalah 0,777 serta efek samping yang paling banyak dikeluhkan pasien adalah hot-flashes 65%. Kata kunci : tamoksifen, disease-free survival, survival rate, efek samping THE EVALUATION OF ADJUVANT TAMOXIFEN THERAPY RESULT IN BREAST CANCER PATIENT AT Dr. M. DJAMIL PADANG HOSPITAL By MUHAMMAD FADHIL 1310311146 ABSTRACT Breast cancer is the most commonly diagnosed cancer among women worldwide. For the last few decades, adjuvant tamoxifen therapy is the most referred therapy. This research aims to evaluate the result of tamoxifen therapy in terms of disease-free survival, survival rate, and the side effect of adjuvant tamoxifen therapy. This retrospective descriptive research was conducted on September 2016 until December 2016 at Dr. M. Djamil Padang Hospital using 100 samples of primary data through interviews and 100 samples of secondary data taken from the medical records of Surgical Oncology of Dr. M. Djamil Padang Hospital. Univariate analysis as well as analysis of Kaplan-Meier method are used in this research. The result of this research shows that the largest age group is 50-59 years old. Disease-free survival of 5 years is 0,727 and survival rate of 5 years is 0,777, along with the most frequently complained side effect by the patient is hot flashes 65%. Keywords: tamoxifen, disease-free survival, survival rate, side effect

Item Type: Thesis (Diploma)
Subjects: R Medicine > RD Surgery
Divisions: Fakultas Kedokteran
Depositing User: s1 pendidikan kedokteran
Date Deposited: 02 Feb 2017 03:01
Last Modified: 02 Feb 2017 03:01
URI: http://scholar.unand.ac.id/id/eprint/22755

Actions (login required)

View Item View Item